Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60c16d764517cf3366a779080804ea4f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dbc3e7608ac2c1394aecf40e0e34b852 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-16 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-25 |
filingDate |
1995-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_090b09c0e7abf1af75166d0036e784e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7ccbeddcf6fe79c03557f73e017b996 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e367c0db15d87fe86c8fc67996cab34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d957356fc2fe6a60382f5186a2669b53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28fbb778e3ef4c6aa9db71821726b7cf |
publicationDate |
1996-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9616172-A2 |
titleOfInvention |
Modulators of anchoring protein function |
abstract |
The present invention provides compositions and methods useful for isolating calcineurin as well as inhibiting calcineurin activity. The compositions are peptides that contain regions that are homologous to calcineurin-binding regions of AKAP 79. Also provided are methods for determining if a cell contains a calcineurin-binding and PKA-binding anchoring protein that are useful for identifying additional proteins that bind both calcineurin and PKA. Another aspect of the present invention is methods for enhancing expression of interleukin 2 by T cells. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0005363-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03012093-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0948343-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0948343-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03012093-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1281756-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7399587-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0028011-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0028011-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7109317-B1 |
priorityDate |
1994-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |